Erratum: Polymorphisms in the NLRP3 gene and risk of primary gouty arthritis (Molecular Medicine Reports (2013) 7 (1761-1766) DOI: 10.3892/mmr.2013.1429);Polymorphisms in the NLRP3 gene and risk of primary gouty arthritis

Molecular Medicine Reports

Volumn 7, Issue 6, 2013, Pages 1761-1766

  Meng, Dong Mei ^a,b   Zhou, Yu Jiao ^b   Luan, Wang ^b   Ren, Wei ^b   Cui, Ling Ling ^b   Han, Lin ^b   Qu, Zheng Hai ^b   Li, Chang Gui ^b   Zhao, Jia Jun ^a  

^a SHANDONG UNIVERSITY   (China)

^b QINGDAO UNIVERSITY   (China)

Author keywords

Gouty arthritis; NLRP3 gene; Primary; Single nucleotide polymorphism

Indexed keywords

CRYOPYRIN;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE AMPLIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GOUT; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84877282973     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1747     Document Type: Erratum

References (36)

1. Roddy E, Zhang W and Doherty M: The changing epidemiology of gout. Nat Clin Pract Rheumatol 3: 443-449, 2007.
2. Terkeltaub R: Gout in 2006: the perfect storm. Bull NYU Hosp Jt Dis 64: 82-86, 2006.
3. Falasca GF: Metabolic diseases: gout. Clin Dermatol 24 :498-508, 2006.
4. Zaka R and Williams CJ: New developments in the epidemiology and genetics of gout. Curr Rheumatol Rep 8: 215-223, 2006.
5. Becker MA and Jolly M: Hyperuricemia and associated diseases. Rheum Dis Clin North Am 32: 275-293, 2006.
6. Mikuls TR and Saag KG: New insights into gout epidemiology. Curr Opin Rheumatol 18: 199-203, 2006.
7. Masseoud D, Rott K, Liu-Bryan R and Agudelo C: Overview of hyperuricaemia and gout. Curr Pharm Des 11: 4117-4124, 2005.
8. Choi HK, Ford ES, Li C and Curhan G: Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 57: 109-115, 2007.
9. Choi HK, De Vera MA and Krishnan E: Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology (Oxford) 47: 1567-1570, 2008.
10. Taniguchi A and Kamatani N: Control of renal uric acid excretion and gout. Curr Opin Rheumatol 20: 192-197, 2008.
11. Shima Y, Teruya K and Ohta H: Association between intronic SNP in urate-anion exchanger gene, SLC22A12, and serum uric acid levels in Japanese. Life Sci 79: 2234-2237, 2006.
12. Vázquez-Mellado J, Jiménez-Vaca AL, Cuevas-Covarrubias S, Alvarado-Romano V, Pozo-Molina G and Burgos-Vargas R: Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology (Oxford) 46: 215-219, 2007.
13. Miao ZM, Zhao SH, Yan SL, Li CG, Wang YG, Meng DM, Zhou L and Mi QS: NALP3 inflammasome functional polymorphisms and gout susceptibility. Cell Cycle 8: 27-30, 2009.
14. Miao ZM, Zhao SH, Wang YG, Li CG, Wang ZC, Chen Y, Chen XY and Yan SL: Epidemiological survey of hyperuricemia and gout in coastal areas of Shandong Province. Chin J Endocrinol Metab 22: 421-425, 2006 (In Chinese).
15. Jin C and Flavell RA: Molecular mechanism of NLRP3 inflammasome activation. J Clin Immunol 30: 628-631, 2010.
16. Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN and Tschopp J: NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20: 319-325, 2004.
17. Martinon F and Tschopp J: Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117: 561-574, 2004.
18. Miao Z, Li C, Chen Y, Zhao S, Wang Y, Wang Z, Chen X, Xu F, Wang F, Sun R, Hu J, Song W, Yan S and Wang CY: Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 35: 1859-1864, 2008.
19. Martinon F: Mechanisms of uric acid crystal-mediated autoinflammation. Immunol Rev 233: 218-232, 2010.
20. Hoffman HM, Mueller JL, Broide DH, Wanderer AA and Kolodner RD: Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 29: 301-305, 2001.
21. Church LD, Cook GP and McDermott MF: Primer: inflammasomes and interleukin 1beta in inflammatory disorders. Nat Clin Pract Rheumatol 4: 34-42, 2008.
22. Pétrilli V and Martinon F: The inflammasome, autoinflammatory diseases, and gout. Joint Bone Spine 74: 571-576, 2007.
23. Masters SL, Lobito AA, Chae J and Kastner DL: Recent advances in the molecular pathogenesis of hereditary recurrent fevers. Curr Opin Allergy Clin Immunol 6: 428-433, 2006.
24. Stojanov S and Kastner DL: Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 17: 586-599, 2005.
25. Kastner DL: Hereditary periodic fever syndromes. Hematology Am Soc Hematol Educ Program: 74-81, 2005.
26. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ and Yü TF: Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20: 895-900, 1977.
27. Barrett JC, Fry B, Maller J and Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265, 2005.
28. Nakamura Y, Kambe N, Saito M, Nishikomori R, Kim YG, Murakami M, Núñez G and Matsue H: Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria. J Exp Med 206: 1037-1046, 2009.
29. Mason DR, Beck PL and Muruve DA: Nucleotide-binding oligomerization domain-like receptors and inflammasomes in the pathogenesis of non-microbial inflammation and diseases. J Innate Immun 4: 16-30, 2012.
30. Yang CS, Shin DM and Jo EK: The Role of NLR-related Protein 3 Inflammasome in Host Defense and Inflammatory Diseases. Int Neurourol J 16: 2-12, 2012.
31. Villani AC, Lemire M, Fortin G, Louis E, Silverberg MS, et al: Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat Genet 41: 71-76, 2009.
32. Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, et al: The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 17: 179-188, 2011.
33. Serlin DM, Kuang PP, Subramanian M, O'Regan A, Li X, Berman JS and Goldstein RH: Interleukin-1beta induces osteopontin expression in pulmonary fibroblasts. J Cell Biochem 97: 519-529, 2006.
34. Qu Y, Ramachandra L, Mohr S, Franchi L, Harding CV, Nunez G and Dubyak GR: P2X7 receptor-stimulated secretion of MHC class II-containing exosomes requires the ASC/NLRP3 inflammasome but is independent of caspase-1. J Immunol 182: 5052-5062, 2009.
35. Eisenbarth SC, Colegio OR, O'Connor W, Sutterwala FS and Flavell RA: Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453: 1122-1126, 2008.
36. Wynn TA: Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 4: 583-594, 2004.